Dawn Mattoon - 07 Jun 2021 Form 4 Insider Report for Quanterix Corp (QTRX)

Role
Sr. VP, Diagnostics
Signature
/s/ Brian Keane, as Attorney-in-Fact
Issuer symbol
QTRX
Transactions as of
07 Jun 2021
Net transactions value
-$400,044
Form type
4
Filing time
09 Jun 2021, 16:03:07 UTC
Previous filing
02 Jun 2021
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTRX Common Stock Options Exercise $56,353 +2,030 +6.2% $27.76 34,763 07 Jun 2021 Direct F1
transaction QTRX Common Stock Options Exercise $75,721 +3,336 +9.6% $22.70 38,099 07 Jun 2021 Direct F1
transaction QTRX Common Stock Options Exercise $179,703 +8,124 +21% $22.12 46,223 07 Jun 2021 Direct F1
transaction QTRX Common Stock Options Exercise $93,803 +4,906 +11% $19.12 51,129 07 Jun 2021 Direct F1
transaction QTRX Common Stock Sale $392,331 -6,883 -13% $57.00 44,246 07 Jun 2021 Direct F1, F2
transaction QTRX Common Stock Sale $413,292 -6,666 -15% $62.00 37,580 07 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTRX Stock Option (right to buy) Options Exercise $0 -2,030 -7.8% $0.000000 23,970 07 Jun 2021 Common Stock 2,030 $27.76 Direct F3
transaction QTRX Stock Option (right to buy) Options Exercise $0 -3,336 -14% $0.000000 21,304 07 Jun 2021 Common Stock 3,336 $22.69 Direct F4
transaction QTRX Stock Option (right to buy) Options Exercise $0 -8,124 -20% $0.000000 31,876 07 Jun 2021 Common Stock 8,124 $22.12 Direct F5
transaction QTRX Stock Option (right to buy) Options Exercise $0 -4,906 -19% $0.000000 21,275 07 Jun 2021 Common Stock 4,906 $19.12 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 17,716 restricted stock units.
F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
F3 The option vests as to 25% of the shares on February 18, 2021 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.
F4 The option vests as to 25% of the shares on March 12, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.
F5 The option vests as to 25% of the shares on February 23, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.
F6 The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.